BioNTech SE (WBO:BNTX) Future 3-5Y EPS without NRI Growth Rate : -85.83 (As of May. 21, 2025)

View and export this data going back to 2020. Start your Free Trial

What is BioNTech SE Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, BioNTech SE's Future 3-5Y EPS without NRI Growth Rate is -85.83.

Competitive Comparison of BioNTech SE's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, BioNTech SE's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioNTech SE's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioNTech SE's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where BioNTech SE's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

BioNTech SE (WBO:BNTX) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

BioNTech SE Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of BioNTech SE's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNTech SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (WBO:BNTX) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

BNTX:USA BNTX:Mexico 22UAd:UK 0A3M:UK 22UA:Germany B1NT34:Brazil 22UA:Bulgaria

Address

An der Goldgrube 12, Mainz, RP, DEU, D-55131

Website

https://www.biontech.de

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.